Atsushi Hirata

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Hematopoietic Stem Cell

Top Venues

British journal of clinical pharmacology

Journal of chemotherapy (Florence, Italy)

Pharmacotherapy

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Ota, Atsushi Hirata, Takeo Hata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study. Pharmacotherapy 44 (7) (2024)
Ryosuke Ota, Atsushi Hirata, Takeo Hata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study. Pharmacotherapy (2024)
Noriaki Kataoka, Takeo Hata, Kouichi Hosomi, Atsushi Hirata, Satoe Fujiwara, Emi Goto, Masami Nishihara, Masahide Ohmichi, Masashi Neo
Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study. Journal of chemotherapy (Florence, Italy) (2024)
Ryosuke Ota, Takeo Hata, Atsushi Hirata, Takeshi Hamada, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: A retrospective cohort study. British journal of clinical pharmacology (2023)
Ryosuke Ota, Takeo Hata, Atsushi Hirata, Takeshi Hamada, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: a retrospective cohort study. British journal of clinical pharmacology (2023)
Takeo Hata, Atsushi Hirata, Ryosuke Ota, Keiko Hosohata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Therapeutics and clinical risk management 18 (2022)
Ryosuke Ota, Atsushi Hirata
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet. Journal of chemotherapy (Florence, Italy) 33 (8) (2021)
Atsushi Hirata, Ryosuke Ota, Takeo Hata, Takeshi Hamada, Masami Nishihara, Kazuhisa Uchiyama, Takahiro Katsumata
Prescribing Trends of Biologic Disease-Modifying Anti-rheumatic Drugs Using a Claims Database from 6 Million People in Japan. Clinical drug investigation 41 (11) (2021)